PREDICTORS OF FATIGUE IN RHEUMATOID ARTHRITIS PATIENTSWHO RECEIVE BIOLOGICAL AND TARGETED SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS

被引：0
|
作者：
Freites Nunez, Dalifer [1 ,2 ]
Redondo, Marta [3 ]
Abasolo, Lydia [1 ,2 ]
Lois, Pia [1 ]
Hernandez, Isabel [1 ]
Vadillo, Cristina [1 ]
Leon, Leticia [2 ,3 ]
机构：
[1] Hosp Clin San Carlos, Rheumatol, Madrid, Spain
[2] Sanitaria Hosp Clin San Carlos IdISSC, Inst Invest, Rheumatol, Madrid, Spain
[3] Univ Camilo Jose Cala, Fac Educ & Salud, Madrid, Spain
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷
关键词：
D O I：
10.1136/annrheumdis-2019-eular.7177
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0246
引用
收藏
页码：1579 / 1580
页数：2
相关论文
共 50 条
  • [21] Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice: results from the ARTIS programme
    Frisell, Thomas
    Bower, Hannah
    Morin, Matilda
    Baecklund, Eva
    Di Giuseppe, Daniela
    Delcoigne, Benedicte
    Feltelius, Nils
    Forsblad-d'Elia, Helena
    Lindqvist, Elisabet
    Lindstroem, Ulf
    Askling, Johan
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (05) : 601 - 610
  • [22] Conventional disease-modifying antirheumatic drugs to treat rheumatoid arthritis
    Rath, T.
    Sander, O.
    Rubbert, A.
    DRUG DEVELOPMENT RESEARCH, 2011, 72 (08) : 657 - 663
  • [23] Effectiveness of tacrolimus concomitant with biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis
    Terabe, Kenya
    Takahashi, Nobunori
    Asai, Shuji
    Hirano, Yuji
    Kanayama, Yasuhide
    Yabe, Yuichiro
    Oguchi, Takeshi
    Fujibayashi, Takayoshi
    Ishikawa, Hisato
    Hanabayashi, Masahiro
    Hattori, Yosuke
    Suzuki, Mochihito
    Kishimoto, Kenji
    Ohashi, Yoshifumi
    Imaizumi, Takahiro
    Imagama, Shiro
    Kojima, Toshihisa
    MODERN RHEUMATOLOGY, 2023, 33 (02) : 292 - 301
  • [24] Effect of biologics and targeted synthetic disease-modifying anti-rheumatic drugs on fatigue in rheumatoid arthritis
    Choy, Ernest H.
    RHEUMATOLOGY, 2019, 58 : 51 - 55
  • [25] Impact of Initiating Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drugs on Pain Medication Use in Patients with Rheumatoid Arthritis
    He, Mengdong
    Lee, Yvonne
    Jin, Yinzhu
    Desai, Rishi
    Vine, Seanna
    Kim, Seoyoung
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1828 - 1830
  • [26] Cardiovascular risk in rheumatoid arthritis patients treated with targeted synthetic and biological disease-modifying antirheumatic drugs: A multi-centre cohort study
    Tong, Xinning
    Shen, Chin-Yao
    Jeon, Ha-Lim
    Li, Yihua
    Shin, Ju-Young
    Chan, Shirley C. W.
    Yiu, Kai Hang
    Pratt, Nicole L.
    Ward, Michael
    Lau, Chak Sing
    Wong, Ian C. K.
    Li, Xue
    Lai, Edward Chia-Cheng
    JOURNAL OF INTERNAL MEDICINE, 2023, 294 (03) : 314 - 325
  • [27] Frequency of Hospitalized Infections Is Reduced in Rheumatoid Arthritis Patients Who Received Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs after 2010
    Ichinose, Kunihiro
    Shimizu, Toshimasa
    Umeda, Masataka
    Fukui, Shoichi
    Nishino, Ayako
    Koga, Tomohiro
    Kawashiri, Shin-ya
    Iwamoto, Naoki
    Tamai, Mami
    Nakamura, Hideki
    Sato, Shuntaro
    Origuchi, Tomoki
    Kawakami, Atsushi
    JOURNAL OF IMMUNOLOGY RESEARCH, 2018, 2018
  • [28] Interruptions of biological and targeted synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: a descriptive cohort study assessing trends in patient characteristics in Switzerland
    Burkard, Theresa
    Vallejo-Yague, Enriqueta
    Huegle, Thomas
    Finckh, Axel
    Burden, Andrea Michelle
    BMJ OPEN, 2022, 12 (03):
  • [29] Discontinuation of Conventional Synthetic Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis and Excellent Disease Control
    Lillegraven, Siri
    Sundlisaeter, Nina Paulshus
    Aga, Anna-Birgitte
    Sexton, Joseph
    Solomon, Daniel H.
    van der Heijde, Desiree
    Haavardsholm, Espen A.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (12): : 1024 - 1026
  • [30] THE LONG-TERM IMPACT OF FATIGUE ON DISEASE ACTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH BIOLOGICAL DISEASE-MODIFYING ANTIRHEUMATIC DRUGS
    Oliveira, D. Santos
    Martins, A.
    Martins, F. R.
    Samoes, B.
    Rato, M.
    Pinheiro, F. Oliveira
    Nicolau, R.
    Vaz, C.
    Bernardes, M.
    Costa, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1307 - 1307
12345